Millennium Management’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-518,275
Closed -$9.7M – 7856
2022
Q1
$9.7M Buy
518,275
+507,967
+4,928% +$9.14M 0.01% 2205
2021
Q4
$220K Sell
10,308
-552,181
-98% -$10.9M ﹤0.01% 5833
2021
Q3
$10.4M Sell
562,489
-275,544
-33% -$5.55M 0.01% 2005
2021
Q2
$17.9M Buy
+838,033
New +$17M 0.01% 1298

Other funds holding OCDX

Millennium Management's OCDX Position: Q2 2022 in Review

Millennium Management sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 518,275 shares — an estimated $9.7M sold.

Millennium Management first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $17.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Millennium Management reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
  • Millennium Management sold 518,275 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $9.7M.
  • Millennium Management first reported a position in Ortho Clinical Diagnostics Holdings in Q2 2021 and held it in 4 quarters.
  • Millennium Management's Ortho Clinical Diagnostics Holdings position peaked at $17.9M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.